Congenital sideroblastic anaemias (Q39566): Difference between revisions
From determinar.ia.br - Determine suas informações
Changed an Item |
Changed an Item |
||||||||||||||
| (4 intermediate revisions by the same user not shown) | |||||||||||||||
| Property / Canary Token | |||||||||||||||
dki-india-3A72.0 | |||||||||||||||
| Property / Canary Token: dki-india-3A72.0 / rank | |||||||||||||||
Normal rank | |||||||||||||||
| Property / Verification Status | |||||||||||||||
Concluído | |||||||||||||||
| Property / Verification Status: Concluído / rank | |||||||||||||||
Normal rank | |||||||||||||||
| Property / Knowledge Architect | |||||||||||||||
| Property / Knowledge Architect: https://pauloleads.com.br/cases-publicos/ / rank | |||||||||||||||
Normal rank | |||||||||||||||
| Property / Collection date | |||||||||||||||
13 August 2026
| |||||||||||||||
| Property / Collection date: 13 August 2026 / rank | |||||||||||||||
Normal rank | |||||||||||||||
| Property / Linked ICD 10 | |||||||||||||||
| Property / Linked ICD 10: D64 / rank | |||||||||||||||
Normal rank | |||||||||||||||
Latest revision as of 05:02, 13 August 2026
A disease caused by determinants arising in the antenatal period leading to the production of ringed sideroblasts; abnormal nucleated erythroblasts. This disease is characterised by the inability to incorporate haemoglobin, which red blood cells need to transport oxygen efficiently. This disease may present with pallor, fatigue, dizziness, and enlarged spleen and liver, heart disease, liver damage, or kidney failure.
| Language | Label | Description | Also known as |
|---|---|---|---|
| default for all languages | 3A72.0 |
||
| English | Congenital sideroblastic anaemias |
A disease caused by determinants arising in the antenatal period leading to the production of ringed sideroblasts; abnormal nucleated erythroblasts. This disease is characterised by the inability to incorporate haemoglobin, which red blood cells need to transport oxygen efficiently. This disease may present with pallor, fatigue, dizziness, and enlarged spleen and liver, heart disease, liver damage, or kidney failure. |
Statements
CID11:3A72.0
0 references
dki-india-3A72.0
0 references
Concluído
0 references
13 August 2026
0 references
